NCT04222530

Brief Summary

The purpose of this clinical study is to compare the accuracy of linear endoscopic ultrasonography and magnified narrowband endoscopy in the diagnosis of invasive depth of early rectal cancer, and to provide more powerful evidence for the choice of surgical methods for early rectal cancer. Patients with early rectal cancer who will be examined by endoscopic ultrasonography or magnifying narrowband endoscopy in the department of gastroenterology and general surgery will be examined by linear endoscopic ultrasonography or magnifying narrowband endoscopy to examine the depth of invasion of early rectal cancer, and the results are compared with the postoperative pathological results of the patients as the gold standard. It provides strong evidence that the accuracy of linear endoscopic ultrasonography in judging the invasive depth of early colorectal cancer is not inferior to that of magnifying narrowband endoscopy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2019

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 10, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

January 28, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

January 10, 2020

Status Verified

December 1, 2019

Enrollment Period

2.4 years

First QC Date

December 16, 2019

Last Update Submit

January 6, 2020

Conditions

Keywords

linear endoscopic ultrasonographyMagnifying narrowband endoscopyDiagnostic accuracy

Outcome Measures

Primary Outcomes (1)

  • Diagnostic accuracy

    The pathological T staging of rectal cancer was selected as the gold standard. The preoperative T staging diagnosis of linear endoscopic ultrasonography and magnifying narrowband endoscopy was compared with the final pathological diagnosis to calculate the diagnostic accuracy of the two methods.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Operating time

    through study completion, an average of 1 year

Study Arms (2)

Linear EUS

EXPERIMENTAL

patients underwent linear endoscopic ultrasonography followed by magnifying narrowband endoscopy

Diagnostic Test: Linear EUS first

ME-NBI

EXPERIMENTAL

patients underwent magnifying narrowband endoscopy followed by linear endoscopic ultrasonography

Diagnostic Test: ME-NBI first

Interventions

Linear EUS firstDIAGNOSTIC_TEST

Linear endoscopic ultrasonography followed by magnifying narrow band endoscopy are used to determine the depth of invasion of early rectal cancer.

Linear EUS
ME-NBI firstDIAGNOSTIC_TEST

Magnifying narrow band endoscopy followed by linear endoscopic ultrasonography are used to determine the depth of invasion of early rectal cancer.

ME-NBI

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Colonoscopic diagnosis of early rectal cancer, the longest diameter \>10mm.
  • Age 18 Mel 80 years old;
  • The subjects are willing to participate in this clinical trial and sign the relevant informed consent form.

You may not qualify if:

  • The coagulation function of the subjects was abnormal and uncontrolled: international standardized ratio ((INR))\>2 or platelet count \<75000 platelets / μ L;
  • Three months before entering the group, there were uncontrolled angina pectoris and / or myocardial infarction, congestive heart failure, lung (respiratory failure), kidney, pancreas, liver disease or other diseases were judged by the researchers to be unable to participate in the study.
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Li L, He J, Hu H, Wang Y, Li W, Huang S, Rownoak J, Xu S, Xie F, Wang J, Mi W, Cai J, Ye Y, Liu S, Wang J, Li Y. Linear-Array Endoscopic Ultrasound and Narrow-Band Imaging Measure the Invasion Depth of Nonpedunculated Rectal Lesions With Comparable Accuracy Based on a Randomized Controlled Trial. Am J Gastroenterol. 2025 Mar 1;120(3):562-569. doi: 10.14309/ajg.0000000000002975. Epub 2024 Jul 25.

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Side Liu, Doctor

    Nanfang Hospital, Southern Medical University

    STUDY DIRECTOR
  • Yue Li, Doctor

    Nanfang Hospital, Southern Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All the subjects who met the inclusion criteria were required to sign an informed consent form before joining the group, but they did not know their own grouping. The team of doctors is composed of four experienced endoscopes from the Department of Gastroenterology of Nanfang Hospital. Patients were randomly divided into group A (patients underwent linear endoscopic ultrasonography followed by magnifying narrowband endoscopy) and group B (patients underwent magnifying narrowband endoscopy first and then linear endoscopic ultrasonography). Different examination items are examined by randomly selected doctors, and the two doctors do not know the diagnosis of the other test. The examination results, examination time and complications were recorded in both groups. After examination, continue to follow up the patient's operation until the patient's surgical and pathological results are obtained.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: This study is a single-center randomized, self-controlled clinical trial. The subjects were selected according to the inclusion and exclusion criteria, and all subjects who met the inclusion criteria were required to sign an informed consent form before joining the group. The team of doctors is composed of four experienced endoscopes from the Department of Gastroenterology of Nanfang Hospital. Patients were randomly divided into group A (patients underwent linear endoscopic ultrasonography followed by magnifying narrowband endoscopy) and group B (patients underwent magnifying narrowband endoscopy first and then linear endoscopic ultrasonography). The examination results, examination time and complications were recorded in both groups. After examination, continue to follow up the patient's operation until the patient's surgical and pathological results are obtained.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2019

First Posted

January 10, 2020

Study Start

January 28, 2020

Primary Completion

June 20, 2022

Study Completion

December 20, 2022

Last Updated

January 10, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

In order to protect privacy, investigators intend not to disclose the information of the participants.